Walleye Trading LLC Nektar Therapeutics Call Options Transaction History

Walleye Trading LLC

$46.7 Billion
Q3 2024

Call Options

20 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 08, 2022	SELL	$3.17 - $6.17 $84,956 - $165,356	-26,800 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$4.16 - $13.72 $69,056 - $227,752	16,600 Added 162.75%	26,800 $144,000
Q4 2021 Feb 14, 2022	SELL	$10.83 - $18.41 $159,201 - $270,627	-14,700 Reduced 59.04%	10,200 $138,000
Q3 2021 Nov 15, 2021	BUY	$13.07 - $18.84 $325,443 - $469,116	24,900 New	24,900 $447,000
Q1 2021 May 17, 2021	SELL	$16.56 - $25.46 $286,488 - $440,458	-17,300 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$15.77 - $19.03 $272,821 - $329,219	17,300 New	17,300 $294,000
Q3 2020 Nov 16, 2020	SELL	$16.59 - $24.79 $63,042 - $94,202	-3,800 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$16.86 - $23.44 $660,912 - $918,848	-39,200 Reduced 91.16%	3,800 $88,000
Q1 2020 May 15, 2020	BUY	$14.47 - $27.96 $279,271 - $539,628	19,300 Added 81.43%	43,000 $768,000
Q4 2019 Feb 14, 2020	SELL	$15.87 - $23.12 $423,729 - $617,304	-26,700 Reduced 52.98%	23,700 $512,000
Q3 2019 Nov 14, 2019	BUY	$16.91 - $36.27 $806,607 - $1.73 Million	47,700 Added 1766.67%	50,400 $918,000
Q2 2019 Aug 14, 2019	SELL	$31.0 - $36.3 $52,700 - $61,709	-1,700 Reduced 38.64%	2,700 $96,000
Q1 2019 May 15, 2019	BUY	$31.58 - $46.35 $123,162 - $180,765	3,900 Added 780.0%	4,400 $148,000
Q4 2018 Feb 14, 2019	SELL	$30.43 - $56.65 $635,987 - $1.18 Million	-20,900 Reduced 97.66%	500 $16,000
Q3 2018 Nov 14, 2018	BUY	$46.46 - $68.49 $706,192 - $1.04 Million	15,200 Added 245.16%	21,400 $1.31 Million
Q2 2018 Aug 14, 2018	SELL	$46.25 - $104.45 $393,125 - $887,825	-8,500 Reduced 57.82%	6,200 $303,000
Q1 2018 May 15, 2018	BUY	$57.4 - $108.44 $665,840 - $1.26 Million	11,600 Added 374.19%	14,700 $1.56 Million
Q4 2017 Feb 14, 2018	SELL	$23.02 - $60.5 $6,906 - $18,150	-300 Reduced 8.82%	3,100 $186,000
Q3 2017 Nov 14, 2017	SELL	$17.79 - $24.0 $96,066 - $129,600	-5,400 Reduced 61.36%	3,400 $82,000
Q2 2017 Aug 14, 2017	BUY	N/A	8,800	8,800 $172,000

Others Institutions Holding NKTR

# of Institutions

146

Shares Held

139M

Call Options Held

32.6K

Put Options Held

14.1K

Deep Track Capital, LP Greenwich, CT

15.9M
Shares

$17 Million
0.76% of portfolio
Black Rock Inc. New York, NY

15.2M
Shares

$16.2 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

13.1M
Shares

$14 Million
0.0% of portfolio
Eventide Asset Management, LLC Boston, MA

9.4M
Shares

$10.1 Million
0.22% of portfolio
Samlyn Capital, LLC New York, NY

9.2M
Shares

$9.84 Million
0.19% of portfolio

View Full List

About NEKTAR THERAPEUTICS

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $201M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

More about NKTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.

Account